Meropenem Hikma

Meropenem, the active ingredient in Meropenem Hikma, is a carbapenem antibiotic presented as an intravenous solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, ventilator‑associated pneumonia, meningitis, and septicemia in hospitalized patients.

GNH USA supplies Meropenem Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat serious bacterial infections that are resistant to other agents.

Complicated intra‑abdominal infections: achieves clinical cure and bacterial eradication. Complicated urinary tract infections: clears infection and prevents recurrence. Hospital‑acquired pneumonia: provides rapid bacterial clearance. Ventilator‑associated pneumonia: improves respiratory outcomes. Meningitis: penetrates the cerebrospinal fluid to eradicate pathogens. Septicemia: rapidly reduces bacteremia and systemic inflammation.

Adverse reactions may occur with any antimicrobial therapy and should be monitored.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Headache - Infusion‑site phlebitis - Elevated liver enzymes

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders - Clostridioides difficile‑associated colitis - Anaphylactic or severe hypersensitivity reactions - Severe neutropenia or leukopenia - Acute renal impairment - Thrombocytopenia or other hematologic abnormalities

Use meropenem with caution and observe clinical monitoring. - Renal function assessment: adjust dose in renal impairment. - Hypersensitivity: discontinue if allergic reaction occurs. - Seizure risk: avoid in patients with pre‑existing CNS disease unless benefits outweigh risks. - Antimicrobial stewardship: limit use to confirmed susceptible infections. - Pregnancy and lactation: only if clearly needed; safety data are limited. - Store at ambient temperature: keep in original container, protect from light and moisture.

Meropenem may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Valproic acid: carbapenems reduce serum valproate levels, risking seizure breakthrough. - Warfarin: may enhance anticoagulant effect, increasing INR. - Aminoglycosides: combined nephrotoxicity risk.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of meropenem. - Other nephrotoxic agents (e.g., NSAIDs, contrast media): monitor renal function. - Oral contraceptives: possible reduced efficacy; advise alternative contraception.